Inactive Instrument

News Recipharm AB (publ)

Equities

RECI B

SE0005757267

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Åsa Bergström New COO at Nanologica AB (publ)	Apr. 11	AQ
Blue Wolf Capital to Acquire OSD CDMO Sites from Recipharm	Apr. 03	AQ
Blue Wolf Capital Partners LLC agreed to acquire Seven manufacturing and development facilities of Recipharm AB.	Apr. 01	CI
Recipharm attains major sustainability milestones	Mar. 27	AQ
Recipharm, Medspray, and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology	Jan. 24	AQ
ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas LNP formulations	Dec. 12	AQ
Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant	Dec. 06	AQ
Synokem Pharmaceuticals Limited acquired 74% stake in Nitin Lifesciences Limited from Recipharm AB.	Nov. 27	CI
Recipharm Announces CEO Changes	Nov. 22	CI
Recipharm Appoints Marc Funk as Board of Directors	Nov. 22	CI
Marc Funk to transition to Recipharm's Board of Directors, Greg Behar appointed new CEO, Inhaled Business to standalone in 2024	Nov. 22	AQ
Fitch Affirm Recipharm at 'B'; Outlook Stable.	23-09-15	AQ
Recipharm - Earthquake in Morocco	23-09-11	AQ
Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy	23-09-06	AQ
Recipharm Announces Executive Appointments	23-08-23	CI
Recipharm and Honeywell to speed development of inhalers with a near-zero global warming potential propellant	23-08-18	AQ
Recipharm's new analytical lab brings impressive testing capabilities to global markets	23-07-12	AQ
NewBiologix SA announced that it has received CHF 45 million in funding from Recipharm AB and other investors	23-05-10	CI
Recipharm Appoints Vikas Gupta as President of ReciBioPharm	23-05-03	CI
Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics	23-05-01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Recipharm AB (publ)

Equities

RECI B

SE0005757267

Summary

Filters